UFP Technologies (UFPT) has recently drawn attention after a period of mixed share performance, with the stock higher over the past 3 months but lower over the past month and week.
Across a longer window, UFP Technologies has been stronger, with a 90 day share price return of 27.38% and a year-to-date share price return of 29.27%. The 1 year total shareholder return of 39.32% and 5 year total shareholder return of 334.27% point to momentum that has been building over time.
Compare UFP Technologies' momentum with a hand-picked 47 high quality undervalued stocks that currently combine quality fundamentals with what may be appealing entry points.
For UFP Technologies, the recent pullback follows a strong multi quarter run, so investors are weighing business progress against a cooler mood around the stock. How does the current share price line up with its fundamentals?
The most followed narrative currently places UFP Technologies' fair value at $355, compared with the last close of $288.79. This suggests a material valuation gap that investors are trying to understand in light of recent operating trends.
The analysts have a consensus price target of $355.0 for UFP Technologies based on their expectations of its future earnings growth, profit margins and other risk factors.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $741.6 million, earnings will come to $102.0 million, and it would be trading on a PE ratio of 33.8x, assuming you use a discount rate of 7.4%.
Investors who want to understand why UFP Technologies might warrant that kind of earnings profile and P/E multiple in a few years may focus on the narrative that leans heavily on compounding revenue, expanding margins and a premium earnings multiple that outpaces many medical equipment peers. The key question is which specific growth and profitability assumptions would need to hold for that valuation to appear consistent.
Result: Fair Value of $355 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, UFP Technologies still faces customer concentration and acquisition integration risks, which could pressure revenue and margins if key relationships or new facilities underperform.
Find out about the key risks to this UFP Technologies narrative.
While analysts see UFP Technologies as undervalued relative to a $355 fair value, our DCF model points the other way. On this view, the current share price of $288.79 sits well above an estimated future cash flow value of $131.25, which implies the stock screens as expensive rather than cheap. Which story do you think fits your own expectations for the business?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out UFP Technologies for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 47 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
With mixed views on UFP Technologies' valuation in mind, now is a good time to review the underlying data yourself and decide where you stand. To see both the potential upsides and the main concerns flagged by our work, take a closer look at the 2 key rewards and 1 important warning sign.
If UFP Technologies has your attention, do not stop here. Use the Simply Wall St Screener to uncover other potential opportunities that fit your investment style.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com